Short answer
Fortrea Holdings Inc. (FTRE) filed its Q3 2025 10-Q quarterly report on Nov 5, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $701M (up 3.9% year over year) with net income of −$16M.
Q3 2025 key financials · XBRL
- Revenue
- $701M
- +3.9% YoY · −1.3% QoQ
- Net income
- −$16M
- +43.0% YoY · +95.8% QoQ
- Operating margin
- -1.2%
- EPS (diluted)
- −$0.16
- +46.7% YoY · +96.1% QoQ
Source: XBRL data from the Fortrea Holdings Inc. (FTRE) Q3 2025 10-Q on SEC EDGAR. USD.
Fortrea Holdings Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added risk factors this quarter; no material changes since December 31, 2024 10-K
- Carried-forward regulatory risk: ongoing exposure to changing healthcare laws affecting product approvals and reimbursement
- Operational risk: supply chain disruptions from global manufacturing constraints impacting near-term production capacity
- Competitive risk: intensified market competition from lower-cost generics and biosimilars eroding market share
- Financial risk: reliance on debt financing with upcoming maturity of $150 million senior notes in Q3 2025
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Fortrea Holdings Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.